These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19317571)

  • 21. Current literature for evidence-based infrainguinal endovascular treatment.
    Meier GH
    Semin Vasc Surg; 2008 Dec; 21(4):210-6. PubMed ID: 19073312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological prevention and management of restenosis.
    Tiroch KA; Byrne RA; Kastrati A
    Expert Opin Pharmacother; 2010 Aug; 11(11):1855-72. PubMed ID: 20486833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To PROTECT or not to PROTECT? In lower extremity angioplasty procedures, "Why Not?" is the question!
    Allie DE
    J Endovasc Ther; 2008 Jun; 15(3):277-82. PubMed ID: 18540706
    [No Abstract]   [Full Text] [Related]  

  • 24. Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses.
    Wohlgemuth WA; Leissner G; Wengenmair H; Bohndorf K; Kirchhof K
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):573-8. PubMed ID: 20671642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts.
    Joviliano EE; Piccinato CE; Dellalibera-Joviliano R; Moriya T; Évora PR
    Ann Vasc Surg; 2011 Aug; 25(6):846-55. PubMed ID: 21620656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coming around for another pass: atherectomy devices may regain lost ground in lower extremity revascularization.
    Lyden SP
    J Endovasc Ther; 2009 Dec; 16(6):663-4. PubMed ID: 19995119
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk of stent thrombosis after lower-extremity endovascular revascularization: which is the optimal antithrombotic therapy and is early strenuous exercise safe?
    Ambrosetti M; Tozzi M; Piffaretti G; Barosi A; Caronno R; Poggio G; Castelli P
    Minerva Cardioangiol; 2008 Apr; 56(2):261-2. PubMed ID: 18319707
    [No Abstract]   [Full Text] [Related]  

  • 28. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
    Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current role of emboli protection devices in percutaneous coronary and vascular interventions.
    Roffi M; Mukherjee D
    Am Heart J; 2009 Feb; 157(2):263-70. PubMed ID: 19185632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technological devices in peripheral percutaneous interventions.
    Anaya-Ayala JE; Chen GJ; Davies MG; Lumsden AB
    Minerva Cardioangiol; 2012 Apr; 60(2):237-55. PubMed ID: 22495172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking potassium channels: a new principle for treating restenosis?
    Olschewski A
    Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
    [No Abstract]   [Full Text] [Related]  

  • 33. An update on endovascular therapy of the lower extremities.
    Bates MC; Aburahma AF
    J Endovasc Ther; 2004 Dec; 11 Suppl 2():II107-127. PubMed ID: 15760252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
    Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment for prevention of restenosis.
    Linde J; Strauss BH
    Expert Opin Emerg Drugs; 2001 Oct; 6(2):281-302. PubMed ID: 15989527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral atherectomy: a critical review.
    Bunting TA; Garcia LA
    J Interv Cardiol; 2007 Dec; 20(6):417-24. PubMed ID: 18042047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From systemic shotgun to site-specific nanoparticle-targeted delivery: a new paradigm for drug delivery.
    Sarembock IJ
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1879-81. PubMed ID: 18946050
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutting balloon: review on principles and background of use in peripheral arteries.
    Cejna M
    Cardiovasc Intervent Radiol; 2005; 28(4):400-8. PubMed ID: 16034656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endovascular treatment of peripheral vascular disease.
    Allaqaband S; Kirvaitis R; Jan F; Bajwa T
    Curr Probl Cardiol; 2009 Sep; 34(9):359-476. PubMed ID: 19664498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. eComment: Femorocrural bypass surgery and intimal hyperplasia.
    Hudorovic N
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):194. PubMed ID: 19628537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.